UK Government tells firms to stockpile medicines for end of Brexit transition

There are concerns that the Covid-19 crisis has led to a dwindling of some medical stocks in the UK.

Suppliers were advised all scenarios must be planned for, including reduced traffic flow at short crossings such as between Calais and Dunkirk, and Dover and Folkestone.

Pharmaceutical companies should stockpile six weeks’ worth of drugs to guard against disruption at the end of the Brexit transition period, the British Government has warned.

The UK's Department of Health and Social Care (DHSC) has written to medicine suppliers advising them to make boosting their reserves a priority.